SciSparc Aims to Change Tourette Syndrome Treatments; Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication
November 10, 2023 09:10 ET
|
SciSparc Ltd
SciSparc to conduct trial at Yale University in the USA, Tel Aviv Sourasky Medical Center in Israel and the Hannover Medical School in Germany TEL AVIV, Israel, Nov. 10, 2023 (GLOBE NEWSWIRE) --...
Germany’s BfArM Joins SNOMED International for Nationwide Use of SNOMED CT
January 06, 2021 08:00 ET
|
SNOMED International
LONDON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has announced their membership in SNOMED International for national use of SNOMED CT from...